We have also found that Alzheimer’s disease, the leading cause of dementia characterized by amyloid-β and tau aggregates, shares a genetic background with a predisposition to PH in patients undergoing reperfusion treatment (raw p-value < 0.05). This evidence concerns the gene MAPT and Alzheimer disease.